DSIP mastery course
Unit 8 of 11

DSIP in context & regulatory status

To judge DSIP fairly, set it beside the sleep drugs that did make it: melatonin agonists, the orexin antagonists…

How DSIP compares to real sleep medicines, and why it never became one

To judge DSIP fairly, set it beside the sleep drugs that did make it: melatonin agonists, the orexin antagonists (DORAs), and the GABAergic hypnotics. Two of those three appear here as names only, because this course’s sources do not cover them; the orexin class is the one it can put dates and trial sizes against, and the contrast there is stark.

This unit places DSIP in that landscape, lays out its actual regulatory status, and explains the specific reasons its development stalled while modern insomnia drugs advanced.

Key terms

The modern sleep-drug landscape


DSIP against a graded comparator


Scoring DSIP against an approved comparator


The regulatory reality


Why development stalled